Curasight is active in the pharmaceutical industry. The company specializes in research and development of various drug candidates. The product portfolio includes, for example, research and development within Positron Emission Tomography (PET) and related ancillary services. The business is operating with the largest presence within Scandinavia. Curasight is headquartered in Copenhagen.

Quotes for Curasight A/S

Right Now

+/-
0.06
%
0,46%
Latest
13.0
High
13.0
Low
13.0
Volume
294
Turnover (DKK)
3 822
Market Value (MDKK)
258,6
Time (Latest trade)

Board

CEO

  • Ulrich Krasilnikoff

Chairperson of the Board

  • Per Falholt

Board

  • Andreas Kjær
  • Charlotte Vedel
  • Kirsten Drejer
  • Lars Trolle
  • Ulrich Krasilnikoff

Videos

Largest Owners

Name Capital % Votes % Date
Andreas Kjaer 30,26 30,26 2021-12-31
UK Curacap ApS 20,01 20,01 2021-12-31
Carsten Haagen Nielsen 12,11 12,11 2021-12-31
Jacob Madsen 4,57 4,57 2021-12-31
Lars Trolle 2,96 2,96 2021-12-31
Per Falholt 0,33 0,33 2021-12-31
Charlotte Vedel 0,20 0,20 2021-12-31
Milou Holding ApS 0,11 0,11 2021-09-20
Krasilnikoff Holding 1 Aps 0,04 0,04 2021-09-20
Kirsten Drejer 0,02 0,02 2021-12-31
Holdings by Modular Finance AB. Compiled and processed data from various sources, including VP Securities, Morningstar and The Danish Financial Supervisory Authority (Finanstilsynet)

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2022-08-25 Delårsrapport 2022-Q2

  • 2022-11-24 Delårsrapport 2022-Q3